Over the past 18 months, there have been numerous tales floating around on Internet forums, social media, and in the news describing a surprisingly simple technique to treat dummy foals that has not only taken the equine world by storm, but fascinated those in human medicine as well. “Watching foals in this state, it was easy to draw a parallel to autism,” Dr. John Madigan, a professor at the University of California Davis and equine neonatal expert told Healthline last May. “We’re measuring something that hasn’t been measured before.”

Madigan and his research colleagues are assessing levels of neurosteroids, chemicals that control, anxiety, depression, and other brain functions. Their hypothesis – derived from previous research – is that children with autism have elevated levels of similar neurosteroids. Although their research is still in the nascent stages, the results could be a tremendous breakthrough for the treatment of individuals with autism spectrum disorder (ASD), which affects an estimated 1.2 million Canadians and has been on the rise since 2012. “I don’t want people to panic,” Dr. Evdokia Anagnostou, a child neurologist and autism researcher at Holland Bloorview in Toronto, told CTV News in 2014 in regards to the increasing numbers. “Yes, the trend is upwards, but it may be the result of
better diagnosis.”

Causes of Dummy Foal

Identified in the 1950’s, neonatal maladjustment syndrome, or “dummy foal” syndrome, is not a disease, but rather identifies foals that behave oddly, usually with abnormal neurological signs, within the first several days of birth. These signs include sleepiness, weakness, circling, a lack of interest in nursing – or in their mothers completely – seizures, hypersensitivity to touch, depression, and atypical vocalization. The condition is also referred to as hypoxic ischemic encephalopathy, peripartum asphyxia syndrome, wanderer foal, or barker foal.

Advertisement